Lista de obras - Marta Valle - Dominio Público Uruguay

A systematic review of inpatient antimicrobial stewardship programmes involving clinical pharmacists in small-to-medium-sized hospitals

artículo científico publicado en 2017

Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers.

artículo científico publicado en 2005

Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome.

artículo científico publicado en 2000

Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.

artículo científico publicado en 2011

CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.

artículo científico publicado en 2004

Characteristics of serum protein binding of felodipine

artículo científico publicado en 1996

Darunavir inhibitory quotient predicts the 48-week virological response to darunavir-based salvage therapy in human immunodeficiency virus-infected protease inhibitor-experienced patients.

artículo científico publicado en 2008

Dealing with Time-Dependent Pharmacokinetics during the Early Clinical Development of a New Leukotriene B4 Synthesis Inhibitor

article

Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.

artículo científico publicado en 2013

Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patients.

artículo científico publicado en 2012

Enantiomeric separation of tramadol and its active metabolite in human plasma by chiral high-performance liquid chromatography: application to pharmacokinetic studies

artículo científico publicado en 1999

Herb-drug interaction between Echinacea purpurea and darunavir/ritonavir in HIV-infected patients.

artículo científico publicado en 2010

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

artículo científico publicado en 2003

Impact of clinical pharmacist intervention on antimicrobial use in a small 164-bed hospital

artículo científico publicado en 2017

Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.

artículo científico publicado en 2016

Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers.

artículo científico publicado en 2002

Levofloxacin weight-adjusted dosing and pharmacokinetic disposition in a morbidly obese patient ⬇️

artículo científico publicado el 6 de abril de 2011

Lopinavir/ritonavir pharmacokinetics in HIV and hepatitis C virus co-infected patients without liver function impairment: influence of liver fibrosis.

artículo científico publicado en 2007

Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca

artículo científico publicado en 2012

Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practice.

artículo científico publicado en 2007

Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans

artículo científico publicado en 2016

Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (-)-O-desmethyltramadol, in rats.

artículo científico publicado en 2000

Pharmacology of ayahuasca administered in two repeated doses

artículo científico publicado en 2011

Population pharmacokinetic modelling of rupatadine solution in 6-11 year olds and optimisation of the experimental design in younger children

artículo científico publicado en 2017

Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patients.

artículo científico publicado en 2016

Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial

artículo científico publicado en 2014

Ritonavir boosting dose reduction from 100 to 50 mg does not change the atazanavir steady-state exposure in healthy volunteers.

artículo científico publicado en 2012

Rupatadine oral solution for 2-5-year-old children with allergic rhinitis: a safety, open-label, prospective study

artículo científico publicado en 2018

Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans

artículo científico publicado en 2015

Saquinavir exposure in HIV-infected patients with chronic viral hepatitis

artículo científico publicado en 2009

Simultaneous determination of tramadol and its major active metabolite O-demethyltramadol by high-performance liquid chromatography with electrochemical detection

artículo científico publicado en 1999

Simultaneous pharmacogenetics-based population pharmacokinetic analysis of darunavir and ritonavir in HIV-infected patients

artículo científico publicado en 2013

Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults.

artículo científico publicado en 2008

Telling true from false: cannabis users show increased susceptibility to false memories

artículo científico publicado en 2015

Treatment simplification to once daily darunavir/ritonavir guided by the darunavir inhibitory quotient in heavily pretreated HIV-infected patients.

artículo científico publicado en 2010

Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs.

artículo científico publicado en 2016

Use of herbal remedies among HIV-infected patients: patterns and correlates

artículo científico publicado en 2011

Uses of pharmaco-EEG and pharmacokinetic-pharmacodynamic modeling in the clinical scenario.

artículo científico publicado en 2002

Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice.

artículo científico publicado en 2006

Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice

artículo científico publicado en 2007

Lista de obras de Marta Valle

A systematic review of inpatient antimicrobial stewardship programmes involving clinical pharmacists in small-to-medium-sized hospitals

Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers.

Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome.

Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.

CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.

Characteristics of serum protein binding of felodipine

Darunavir inhibitory quotient predicts the 48-week virological response to darunavir-based salvage therapy in human immunodeficiency virus-infected protease inhibitor-experienced patients.

Dealing with Time-Dependent Pharmacokinetics during the Early Clinical Development of a New Leukotriene B4 Synthesis Inhibitor

Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.

Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patients.

Enantiomeric separation of tramadol and its active metabolite in human plasma by chiral high-performance liquid chromatography: application to pharmacokinetic studies

Herb-drug interaction between Echinacea purpurea and darunavir/ritonavir in HIV-infected patients.

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

Impact of clinical pharmacist intervention on antimicrobial use in a small 164-bed hospital

Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.

Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers.

Levofloxacin weight-adjusted dosing and pharmacokinetic disposition in a morbidly obese patient ⬇️

Lopinavir/ritonavir pharmacokinetics in HIV and hepatitis C virus co-infected patients without liver function impairment: influence of liver fibrosis.

Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca

Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practice.

Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans

Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (-)-O-desmethyltramadol, in rats.

Pharmacology of ayahuasca administered in two repeated doses

Population pharmacokinetic modelling of rupatadine solution in 6-11 year olds and optimisation of the experimental design in younger children

Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patients.

Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial

Ritonavir boosting dose reduction from 100 to 50 mg does not change the atazanavir steady-state exposure in healthy volunteers.

Rupatadine oral solution for 2-5-year-old children with allergic rhinitis: a safety, open-label, prospective study

Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans

Saquinavir exposure in HIV-infected patients with chronic viral hepatitis

Simultaneous determination of tramadol and its major active metabolite O-demethyltramadol by high-performance liquid chromatography with electrochemical detection

Simultaneous pharmacogenetics-based population pharmacokinetic analysis of darunavir and ritonavir in HIV-infected patients

Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults.

Telling true from false: cannabis users show increased susceptibility to false memories

Treatment simplification to once daily darunavir/ritonavir guided by the darunavir inhibitory quotient in heavily pretreated HIV-infected patients.

Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs.

Use of herbal remedies among HIV-infected patients: patterns and correlates

Uses of pharmaco-EEG and pharmacokinetic-pharmacodynamic modeling in the clinical scenario.

Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice.

Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice